Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01007760 · ClinicalTrials.gov registry record · NA
Dose-dependent Effects of Second-hand Smoke on Vascular Function
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT01007760 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 33 participants.
The verdict
NCT01007760, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the vascular effects of brief second-hand smoke exposure on normal healthy individuals.
Interventions
- OTHER Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01007760
The ClinicalTrials.gov registry entry for NCT01007760 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke is the first listed.
NCT01007760 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01007760 about?
NCT01007760 is a clinical study titled "Dose-dependent Effects of Second-hand Smoke on Vascular Function". The purpose of this study is to determine the vascular effects of brief second-hand smoke exposure on normal healthy individuals.
What is the current status of trial NCT01007760?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2009-11. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01007760?
The interventions under investigation include: Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke (OTHER).
Who is sponsoring clinical trial NCT01007760?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.